Profile data is unavailable for this security.
About the company
Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products.
- Revenue in EUR (TTM)43.86bn
- Net income in EUR-1.50bn
- LocationBayer AGKaiser-Wilhelm-Allee 1LEVERKUSEN 51373GermanyDEU
- Phone+49 214301
- Fax+49 2 143066328
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|BAYX.N:GER since |
|Bluerock Therapeutics LP||Announced||08 Aug 2019||08 Aug 2019Announced||28.26%||600.00m|
|Maty's Healthy Products LLC||Deal completed||11 Jul 2019||11 Jul 2019Deal completed||26.82%||--|